Scott Coiante - Agile Thrpe CFO and VP
| AGRXDelisted Stock | USD 2.94 0.08 2.65% |
CFO
Mr. Scott M. Coiante is Senior Vice President of Agile Therapeutics, Inc. He is no longer Chief Financial Officer of the Company, effective August 5, 2019. Beginning in 2005, Beginning in 2005, he served as Vice President Finance, Treasurer, Principal Accounting Officer at Medarex, Inc., a publicly listed biopharmaceutical company, which BristolMyers Squibb Co., acquired in September 2009 and during 2002 through 2005, he served as Director of Finance. While at Medarex, he was responsible for corporate financial functions including treasury, accounting, SEC reporting, tax and assurance. From 1989 to 2002, he held management positions of increasing responsibilities at Ernst Young LLP, which included managing audit engagements, financial preparation, and financial reporting for client public offerings, both initial and followon, and SEC registration filing statements for both public and private companies, predominantly within the life science and pharmaceutical industries. since 2019.
| Age | 57 |
| Tenure | 5 years |
| Phone | 609 683 1880 |
| Web | https://www.agiletherapeutics.com |
Agile Thrpe Management Efficiency
The company has return on total asset (ROA) of (0.9671) % which means that it has lost $0.9671 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.6404) %, meaning that it created substantial loss on money invested by shareholders. Agile Thrpe's management efficiency ratios could be used to measure how well Agile Thrpe manages its routine affairs as well as how well it operates its assets and liabilities.Agile Thrpe currently holds 2.21 M in liabilities with Debt to Equity (D/E) ratio of 3.95, implying the company greatly relies on financing operations through barrowing. Agile Thrpe has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Agile Thrpe's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 4 records | CFO Age | ||
| John Morberg | Lifecore Biomedical | 60 | |
| Ryan CPA | Lifecore Biomedical | 47 | |
| John CMA | Cumberland Pharmaceuticals | 68 | |
| Joshua Fine | Cyclo Therapeutics | 42 | |
Management Performance
| Return On Equity | -13.64 | |||
| Return On Asset | -0.97 |
Agile Thrpe Leadership Team
Elected by the shareholders, the Agile Thrpe's board of directors comprises two types of representatives: Agile Thrpe inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agile. The board's role is to monitor Agile Thrpe's management team and ensure that shareholders' interests are well served. Agile Thrpe's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agile Thrpe's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD MBA, Senior Officer | ||
| Jason Butch, VP Officer | ||
| Joseph DUrso, Controller | ||
| Robert ME, Senior Officer | ||
| Kathryn PharmD, Advisor | ||
| Alfred Altomari, CEO and President and Director | ||
| Matthew Riley, Head Communications | ||
| Amy Welsh, Senior Officer | ||
| Geoffrey Gilmore, Senior Officer | ||
| Scott Coiante, CFO and VP | ||
| MPH MD, Consultant |
Agile Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agile Thrpe a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.64 | |||
| Return On Asset | -0.97 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 633.86 K | |||
| Shares Outstanding | 2.96 M | |||
| Shares Owned By Insiders | 1.13 % | |||
| Shares Owned By Institutions | 10.13 % | |||
| Number Of Shares Shorted | 222.1 K | |||
| Price To Earning | (4.74) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Agile Stock
If you are still planning to invest in Agile Thrpe check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Agile Thrpe's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |